2024-11-28 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Analysis Report

**1. Performance Relative to S&P 500 (VOO):**

Colgate-Palmolive Co (CL) is a multinational consumer goods company that manufactures and sells a wide range of personal care, home care, and pet care products.  The cumulative return of CL (50.55%) significantly lags behind the S&P 500 (VOO) cumulative return (128.86%) over the analyzed period.  The difference is -78.3%, placing it at the 8.8th percentile of the historical relative performance range (-86.5% to 7.2%). This indicates that CL has underperformed the market considerably.

**Alpha and Beta Analysis:**

The provided data shows inconsistent alpha (outperformance relative to the market) and beta (volatility relative to the market) values over the years. While alpha is mostly positive, indicating occasional outperformance, it's not consistently high. Beta values are generally around 1, suggesting similar volatility to the market. Market capitalization (Cap(B)) fluctuates but remains consistently large.  MDD (Maximum Drawdown) shows periods of significant price declines.


**2. Recent Price Movement:**

* **Last Closing Price:** $96.76
* **5-Day Moving Average:** $95.57
* **20-Day Moving Average:** $93.40
* **60-Day Moving Average:** $98.77

The current price is slightly above the 5-day and 20-day moving averages, suggesting a recent upward trend, but below the 60-day moving average, indicating a potential short-term correction from a higher price level.

**3. Technical Indicators and Relative Divergence:**

* **RSI (Relative Strength Index):** 77.2 – This indicates the stock is in overbought territory, suggesting a potential pullback.
* **PPO (Percentage Price Oscillator):** 0.81 – A positive value suggests upward momentum.
* **20-Day Relative Divergence:** +3.0 – This confirms a short-term upward trend.

The current price ($96.76) is relatively close to recent highs; although not a sharp jump, there is no evidence of a recent drastic price movement.  The expected return is 0.0%, meaning that over a long-term (2+ years) buy-and-hold strategy, the expected return is not expected to exceed that of the S&P 500.

**4. Recent Financial Performance and Outlook:**

The provided earnings data shows relatively stable revenue around $5 billion per quarter and EPS around $0.85-$0.90.  There is no prediction data, therefore we cannot compare the latest result with the predicted result.  While revenue is consistent, a thorough analysis requires a comparison to previous periods and industry benchmarks.  More context (e.g., year-over-year growth rates, earnings guidance) is necessary for a more comprehensive assessment.

**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue is relatively stable, but profit margins show a slight downward trend from 61.08% to 58.54% over the reported period.
* **Capital and Profitability:**  ROE (Return on Equity) is highly volatile and shows extreme variations, suggesting potential issues in accounting methodology or underlying business operations.  Further investigation into the causes of these fluctuations is needed.  Negative equity in one quarter (-0.01B) raises significant concerns.

**6. News and Recent Issues:**

* *Further information is needed on recent news within the last two days from sources like Shacknews or Finbold regarding earnings reports, analyst opinions, and market outlook.*  This section requires additional external data.

**7. Comprehensive Analysis:**

Colgate-Palmolive's performance has lagged behind the broader market significantly. While recent price movements show a short-term uptrend, the overbought RSI and inconsistent performance indicators suggest caution.  The substantial negative divergence between CL and VOO, coupled with volatile ROE figures and the need for further investigation into negative equity, raises concerns about long-term investment potential.  The lack of recent news, and therefore the current market outlook and analyst opinions, significantly limits a comprehensive investment assessment.  Additional information, especially pertaining to the inconsistencies in ROE and the negative equity, is critical.

**8. Recommendations:**

Given the underperformance, overbought conditions, and volatility in key financial metrics, a cautious approach is warranted. Further research into the underlying reasons for inconsistent ROE and negative equity, coupled with a comprehensive review of recent news and analyst opinions, is recommended before making any investment decisions.  The current data suggests that CL is a high-risk investment.
